BIAF Stock Analysis: Buy, Sell, or Hold?
BIAF - bioAffinity Technologies, Inc. Common Stock
$0.70
-0.07 (-8.70%)
▼
5d:
-13.4%
30d:
-53.95%
90d:
-79.11%
WAIT
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 13, 2026
29d
Get Alerted When BIAF Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
8 traders called BIAF this week
81% bullish • 5 bearish
81% bullish • 5 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: BIAF is down 13.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: BIAF is down 13.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: BIAF is currently trading at $0.70, which is considered slightly low relative to its 30-day fair value range of $0.77 to $1.57.
Technical Outlook: Technically, BIAF is in a downtrend. Immediate support is located at $0.61, while resistance sits at $0.87. Short-term momentum is weak, with the stock down 8.7% recently.
Market Sentiment: BIAF has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.00 (+757.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BIAF is in a downtrend. Immediate support is located at $0.61, while resistance sits at $0.87. Short-term momentum is weak, with the stock down 8.7% recently.
Market Sentiment: BIAF has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.00 (+757.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.77 -
$1.57
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-8.7%)
- BULLISH: Trading 757.3% below Wall St target ($6.00)
- WARNING: Recommendation downgraded due to -13.4% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.77 -
$1.57
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.61
Resistance Level
$0.87
Current Trend
Downtrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.09
Wall Street Target
$6.00
(+757.3%)
Revenue Growth (YoY)
-27.1%
Profit Margin
-280.6%
Share & Embed Analysis
Last updated: July 14, 2026 7:15 AM ET
Data refreshes hourly during market hours. Next update: 8:15 AM
Data refreshes hourly during market hours. Next update: 8:15 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BIAF showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$591 | 64 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 67 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$157 | 60 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$271 | 54 HOLD |
